Biogen BIIB
NASDAQ BIIB
$253.84 +12.86 (+5.34%)
At close: Oct 22, 2026 · 4:00 PM EDT

Biogen (BIIB) Equity Income (2012 - 2022)

Updated

Biogen's Equity Income was $2.6 million in FY2022, down 92.6% from $34.9 million in FY2021.

Analysis

Biogen (BIIB) Equity Income (2012 - 2022) Analysis & Trends

From FY2012 onward, Biogen has reported Equity Income for 8 years.

  • The FY2022 figure marks the lowest annual Equity Income since FY2019.
  • Per Business Quant data, Equity Income in earlier years was $34.9 million in FY2021 (+957.6%), $3.3 million in FY2020 and -$77.4 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -10.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Biogen 37.51 Bn 24.16 Bn 1.96 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 5.90 Mn
Mar 31, 2022 -3.30 Mn
Dec 31, 2021 17.70 Mn
Sep 30, 2021 1.10 Mn
Jun 30, 2021 34.30 Mn
Mar 31, 2021 -18.20 Mn
Dec 31, 2020 18.00 Mn
Sep 30, 2020 -13.10 Mn
Jun 30, 2020 15.10 Mn
Mar 31, 2020 -16.80 Mn
Dec 31, 2019 -140.90 Mn
Sep 30, 2019 -21.80 Mn
Jun 30, 2019 -16.30 Mn
Mar 31, 2019 -28.70 Mn
Sep 30, 2015 -6.80 Mn
Jun 30, 2015 -4.90 Mn
Mar 31, 2015 -800,000.00
Dec 31, 2014 -168,000.00
Sep 30, 2014 -5.39 Mn
Jun 30, 2014 -1.93 Mn
API Access

Biogen Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=BIIB&period=max&api_key=YOUR_API_KEY